12.10Open12.20Pre Close224 Volume903 Open Interest250.00Strike Price114.22KTurnover2007.73%IV-0.02%PremiumDec 20, 2024Expiry Date4.56Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8458Delta0.0541Gamma50.09Leverage Ratio-1796.1865Theta0.0000Rho-42.36Eff Leverage0.0005Vega
Alnylam Pharmaceuticals Stock Discussion
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet